News

Eureka call for international biotech innovation projects

Published on | 1 month ago

Programmes
Health Agro-Food, Environment
Flemish companies active in biotechnology can apply to the Eureka Biotech Call for Innovation Projects, an international funding opportunity supporting collaborative research and innovation projects with partners from participating countries. Each country or region assesses and funds its own project partners. For Flanders, VLAIO participates through its regular support for research and development projects, in accordance with the applicable criteria.

Through this Eureka call, Flanders aims to encourage companies to set up research and development projects in biotechnology fields such as medicine, bioinformatics, pharmaceutical products and services, life sciences, digitalisation and (bio)process technology (non-exhaustive list) – in collaboration with partners.

Besides the joint Eureka application, Flemish participants must also submit a project proposal to VLAIO and are encouraged to contact VLAIO early for an eligibility check and proposal guidance. The Eureka submission deadline is 25 September 2026. The VLAIO proposal deadline is 9 October 2026 12:00 CEST

More information and details on the dedicated VLAIO webpage

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1961 articles available search in articles 

Testimonial

image of iCARE4CVD: Thomas More participates in research on improving patient care

iCARE4CVD: Thomas More participates in research on improving patient care

Funded under Horizon Europe’s Innovative Health Initiative (HORIZON-JU-IHI-2022-02-01) and running from 2023 to 2028, the iCARE4CVD project aims to improve patient care across the board, starting from those at risk of developing cardiovascular disease to those with advanced heart failure. Thomas More University of Applied Sciences plays an important role in the project focusing data analysis and AI modeling as well as on the implementation of Patient-Reported Outcome Measures and Patient-Reported Experience Measures. Find out more in the full article.